Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Diplomat Pharmacy, Inc. (DPLO) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $3.99 Metrics
OS: 76.0 M -495 % ROE
Market cap: $303 M -50 % ROIC
Net debt: $540 M
EV: $843 M

 
TTM Valuation
EBITDA ($9.4) M
EBIT ($92.4) M
EPS ($8.69)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11
Revenues5,492.54,485.24,410.43,366.62,215.01,515.11,126.9772.0
            Revenue growth22.5%1.7%31.0%52.0%46.2%34.4%46.0% 
Cost of goods sold5,116.54,211.14,144.83,103.42,074.81,426.11,057.6715.4
Gross profit376.0274.1265.6263.2140.189.069.356.5
            Gross margin6.8%6.1%6.0%7.8%6.3%5.9%6.2%7.3%
Selling, general and administrative335.7255.6213.7217.3127.677.964.447.4
EBITA108.660.481.170.210.410.04.79.1
            EBITA margin2.0%1.3%1.8%2.1%0.5%0.7%0.4%1.2%
Amortization of intangibles68.541.833.924.24.0   
EBIT40.018.647.245.96.410.04.79.1
            EBIT margin0.7%0.4%1.1%1.4%0.3%0.7%0.4%1.2%
Pre-tax income-307.38.136.241.09.2-26.1-2.69.2
Income taxes-5.0-7.111.216.24.70.00.00.0
            Tax rate1.6% 30.9%39.6%50.6%0.0%0.0%0.0%
Net income-302.315.528.325.84.3-26.1-2.69.2
            Net margin-5.5%0.3%0.6%0.8%0.2%-1.7%-0.2%1.2%
 
Diluted EPS($4.07)$0.23$0.42$0.41$0.11($0.79)($0.08)$2,271.28
Shares outstanding (diluted)74.268.868.063.138.633.133.10.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy